Aptamer-guided DNA tetrahedrons as a photo-responsive drug delivery system for Mucin 1-expressing breast cancer cells
Source abstract
Abstract
Abstract Photosensitizers are crucial for photodynamic therapy. However, conventional photosensitizers have poor selectivity, and their targeted delivery by nanocarriers has become a major research focus. The aim of this study was to construct a targeted delivery system for new photosensitizers using aptamer-guided DNA tetrahedra. Mucin 1 protein is overexpressed in some cancer cells. The sequence of a Mucin 1 aptamer (MUC1) was linked to a DNA tetrahedron to form MUC1 aptamer-modified tetrahedral nanostructures (MUC1-TDNs) for the selective targeting of MUC1-positive tumor cells. The photosensitizer, TMPyP4, was loaded into MUC1-TDNs owing to the high affinity of TMPyP4 for DNA; consequently, a targeted photosensitizer delivery system (MUC1-TDNs-TMPyP4, MTT) was obtained. This system allowed for the selective delivery of TMPyP4 to MUC1-positive cancer cells. Moreover, MTT promoted the production of reactive oxygen species as well as cytotoxicity in MUC1-positive cells, while less killing effect were observed in MUC1-negative cells. We designed a MUC1-targeted delivery system of photosensitizers based on DNA tetrahedron, thus providing a new approach for the targeted release of photosensitizers.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Advanced biosensing and bioanalysis techniques · Photodynamic Therapy Research Studies · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (47)
Show source-provided references
1. Photodynamic therapy - mechanisms, photosensitizers and combinations10.1016/j.biopha.2018.07.049 ↗
2. Nature: a rich source for developing multifunctional agents. Tumor-imaging and photodynamic therapy10.1002/lsm.20352 ↗
3. Proteasome inhibition potentiates antitumor effects of photodynamic therapy in mice through induction of endoplasmic reticulum stress and unfolded protein response10.1158/0008-5472.CAN-08-3439 ↗
4. Photodynamic therapy in oncology10.1634/theoncologist.11-9-1034 ↗
5. Antitumor effects of telomerase inhibitor TMPyP4 in osteosarcoma cell lines10.1002/jor.21451 ↗
6. The cationic porphyrin TMPyP4 down-regulates c-MYC and human telomerase reverse transcriptase expression and inhibits tumor growth in vivo
7. Telomerase inhibition and cell growth arrest by G-quadruplex interactive agent in multiple myeloma
8. TMPYP4 exerted antitumor effects in human cervical cancer cells through activation of p38 mitogen-activated protein kinase10.1186/s40659-017-0129-4 ↗
9. Enhanced G4-DNA binding of 5,10,15,20 (N-propyl-4-pyridyl) porphyrin (TPrPyP4): a comparative study with TMPyP410.1039/c0cc01912g ↗
10. Three-dimensional structure of RNA monomeric G-quadruplex containing ALS and FTD related G4C2 repeat and its binding with TMPyP4 probed by homology modeling based on experimental constraints and molecular dynamics simulations10.1021/acschemneuro.9b00572 ↗
11. Binding of telomestatin, TMPyP4, BSU6037, and BRACO19 to a telomeric G-quadruplex-duplex hybrid probed by all-atom molecular dynamics simulations with explicit solvent10.1021/acsomega.8b01574 ↗
12. The cationic porphyrin TMPyP4 destabilizes the tetraplex form of the fragile X syndrome expanded sequence d(CGG)n10.1093/nar/gkg453 ↗
13. Simple peptide-tuned self-assembly of photosensitizers towards anticancer photodynamic therapy10.1002/anie.201509810 ↗
14. RGD-modified albumin nanoconjugates for targeted delivery of a porphyrin photosensitizer10.1021/acs.molpharmaceut.7b00321 ↗
15. Gold mining for PDT: great expectations from tiny nanoparticles10.1016/j.pdpdt.2015.03.002 ↗
16. Dual stimuli-responsive vesicular nanospheres fabricated by lipopolymer hybrids for tumor-targeted photodynamic therapy10.1021/acs.biomac.5b01474 ↗
17. The development and characterisation of porphyrin isothiocyanate-monoclonal antibody conjugates for photoimmunotherapy10.1038/sj.bjc.6602517 ↗
18. Targeted and effective photodynamic therapy for cancer using functionalized nanomaterials10.1016/j.apsb.2016.01.007 ↗
19. Design, fabrication and applications of tetrahedral DNA nanostructure-based multifunctional complexes in drug delivery and biomedical treatment10.1038/s41596-020-0355-z ↗
20. Single-particle tracking and modulation of cell entry pathways of a tetrahedral DNA nanostructure in live cells10.1002/anie.201403236 ↗
21. Tetrahedral framework nucleic acids deliver antimicrobial peptides with improved effects and less susceptibility to bacterial degradation10.1021/acs.nanolett.0c00529 ↗
22. An intelligent DNA nanorobot with in vitro enhanced protein Lysosomal degradation of HER210.1021/acs.nanolett.9b01320 ↗
23. Tetrahedral DNA nanostructure-delivered DNAzyme for gene silencing to suppress cell growth10.1021/acsami.8b22444 ↗
24. DNA-Based nanomedicine with targeting and enhancement of therapeutic efficacy of breast cancer cells10.1021/acsami.9b03449 ↗
25. Aptamer-modified tetrahedral DNA nanostructure for tumor-targeted drug delivery10.1021/acsami.7b13328 ↗
26. Tetrahedral framework nucleic acids promote corneal epithelial wound healing in vitro and in vivo
27. Enhanced neural regeneration with a concomitant treatment of framework nucleic acid and stem cells in spinal cord injury10.1021/acsami.9b19079 ↗
28. Tetrahedral framework nucleic acid inhibits chondrocyte apoptosis and oxidative stress through activation of autophagy10.1021/acsami.0c17307 ↗
29. Progress in biomedical applications of tetrahedral framework nucleic acid-based functional systems10.1021/acsami.0c13806 ↗
30. Tetrahedral framework nucleic acids promote scarless healing of cutaneous wounds via the AKT-signaling pathway10.1038/s41392-020-0173-3 ↗
31. Effects of tetrahedral DNA nanostructures on autophagy in chondrocytes10.1039/C7CC09397G ↗
32. Nucleic acids and analogs for bone regeneration10.1038/s41413-018-0042-7 ↗
33. Aptamer-based tumor-targeted drug delivery for photodynamic therapy10.1021/nn901374b ↗
34. MUC1-C Oncoprotein Blocks terminal differentiation of chronic myelogenous leukemia Cells by a ROS-mediated mechanism10.1177/1947601911405044 ↗
35. MUC1: a multifunctional cell surface component of reproductive tissue epithelia10.1186/1477-7827-2-4 ↗
36. Mucins in cancer: function, prognosis and therapy10.1038/nrc2761 ↗
37. Improved in vivo delivery of m-THPC via pegylated liposomes for use in photodynamic therapy10.1016/j.jconrel.2011.09.085 ↗
38. Tumor-targeting nanogel that can function independently for both photodynamic and photothermal therapy and its synergy from the procedure of PDT followed by PTT10.1016/j.jconrel.2013.07.006 ↗
39. Intracellular photodynamic therapy with photosensitizer-nanoparticle conjugates: cancer therapy using a 'Trojan horse'
40. Photodynamic therapy for cancer10.1038/nrc1071 ↗
41. The p53/p21 complex regulates cancer cell invasion and apoptosis by targeting Bcl-2 family proteins10.1158/0008-5472.CAN-16-2098 ↗
42. Inhibition of mitochondrial matrix chaperones and antiapoptotic Bcl-2 family proteins empower antitumor therapeutic responses10.1158/0008-5472.CAN-16-3424 ↗
43. Old, new and emerging functions of caspases10.1038/cdd.2014.216 ↗
44. Thermodynamics of G-tetraplex formation by telomeric DNAs10.1021/bi00053a027 ↗
45. Effect of telomere and telomerase interactive agents on human tumor and normal cell lines
46. Antiviral activity of the G-Quadruplex ligand TMPyP4 against herpes simplex virus-110.3390/v13020196 ↗
47. Porphyrin binding mechanism is altered by protonation at the loops in G-quadruplex DNA formed near the transcriptional activation site of the human c-kit gene10.1016/j.bbagen.2012.09.006 ↗